obesity glp-1 news today Clinical Trials GLP-1 Prescriptions Quadruple Since 2021

Waters DD, Ho JE, Boekholdt SM, DeMicco DA, Kastelein JJ, Messig M, et al

Although studies determining the structure of GLP-1 bound to the N-terminal, extracellular domain of the receptor showed that the residues 13-33 of the GLP-1 peptide analogs form a helical structure (PDB ID 3iol, Underwood et al., 2010), recent EM structures of the whole receptor bound to the GLP-1 protein (PDB ID 6x18, Zhang et al., 2020) shows that the entire GLP-1 peptide forms a long helix as it binds to its receptor

It was approved in 2023 for geographic atrophy (GA) secondary to AMD, but its current label only recommends treatment for up to 12 months

The launch reflects the companys readiness to enter the segment immediately following patent expiry and expand access to advanced treatment options

A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of alzheimers disease